280 related articles for article (PubMed ID: 17408646)
21. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.
Bull SJ; Huezo-Diaz P; Binder EB; Cubells JF; Ranjith G; Maddock C; Miyazaki C; Alexander N; Hotopf M; Cleare AJ; Norris S; Cassidy E; Aitchison KJ; Miller AH; Pariante CM
Mol Psychiatry; 2009 Dec; 14(12):1095-104. PubMed ID: 18458677
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.
Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
J Psychopharmacol; 2005 Mar; 19(2):166-72. PubMed ID: 15728438
[TBL] [Abstract][Full Text] [Related]
23. Interferon-alpha-induced modulation of glucocorticoid and serotonin receptors as a mechanism of depression.
Cai W; Khaoustov VI; Xie Q; Pan T; Le W; Yoffe B
J Hepatol; 2005 Jun; 42(6):880-7. PubMed ID: 15885359
[TBL] [Abstract][Full Text] [Related]
24. Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin.
Kraus MR; Schäfer A; Wissmann S; Reimer P; Scheurlen M
Clin Pharmacol Ther; 2005 Jan; 77(1):90-100. PubMed ID: 15637534
[TBL] [Abstract][Full Text] [Related]
25. Interaction among childhood trauma and functional polymorphisms in the serotonin pathway moderate the risk of depressive disorders.
Van der Auwera S; Janowitz D; Schulz A; Homuth G; Nauck M; Völzke H; Rose M; Meyer zu Schwabedissen H; Freyberger HJ; Grabe HJ
Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S45-54. PubMed ID: 25214390
[TBL] [Abstract][Full Text] [Related]
26. Depressive symptoms in patients with hepatitis C treated with pegylated interferon alpha therapy: a 24-week prospective study.
Pavlović Z; Delić D; Marić NP; Vuković O; Jašović-Gašić M
Psychiatr Danub; 2011 Dec; 23(4):370-7. PubMed ID: 22075738
[TBL] [Abstract][Full Text] [Related]
27. Risk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphism.
Lotrich FE; Ferrell RE; Rabinovitz M; Pollock BG
Biol Psychiatry; 2009 Feb; 65(4):344-8. PubMed ID: 18801474
[TBL] [Abstract][Full Text] [Related]
28. Factors influencing long-term changes in mental health after interferon-alpha treatment of chronic hepatitis C.
Schmidt F; Janssen G; Martin G; Lorenz R; Loeschke K; Soyka M; Folwaczny C; Schaefer M
Aliment Pharmacol Ther; 2009 Nov; 30(10):1049-59. PubMed ID: 19691667
[TBL] [Abstract][Full Text] [Related]
29. Influence of TPH2 and HTR1A polymorphisms on lifelong premature ejaculation risk among the chinese Han population.
Wang F; Luo D; Chen J; Pan C; Wang Z; Fu H; Xu J; Yang M; Mo S; Zhuang L; Wang W
BMC Urol; 2023 May; 23(1):86. PubMed ID: 37161455
[TBL] [Abstract][Full Text] [Related]
30. Specific serotonin reuptake inhibitors prevent interferon-α-induced depression in patients with hepatitis C: a meta-analysis.
Jiang HY; Deng M; Zhang YH; Chen HZ; Chen Q; Ruan B
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1452-60.e3. PubMed ID: 23648373
[TBL] [Abstract][Full Text] [Related]
31. [Depressive symptoms during treatment with interferon alpha for HCV infection--preliminary report].
Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Andrzej K
Psychiatr Pol; 2006; 40(4):799-808. PubMed ID: 17068951
[TBL] [Abstract][Full Text] [Related]
32. Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha.
Lotrich FE; Ferrell RE; Rabinovitz M; Pollock BG
Clin Neuropharmacol; 2010 Jul; 33(4):191-7. PubMed ID: 20661026
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression.
Kraus MR; Schäfer A; Al-Taie O; Scheurlen M
J Viral Hepat; 2005 Jan; 12(1):96-100. PubMed ID: 15655055
[TBL] [Abstract][Full Text] [Related]
34. Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: A critical systematic review.
Machado MO; Oriolo G; Bortolato B; Köhler CA; Maes M; Solmi M; Grande I; Martín-Santos R; Vieta E; Carvalho AF
J Affect Disord; 2017 Feb; 209():235-245. PubMed ID: 27936453
[TBL] [Abstract][Full Text] [Related]
35. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.
Schaefer M; Schwaiger M; Garkisch AS; Pich M; Hinzpeter A; Uebelhack R; Heinz A; van Boemmel F; Berg T
J Hepatol; 2005 Jun; 42(6):793-8. PubMed ID: 15885349
[TBL] [Abstract][Full Text] [Related]
36. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
[TBL] [Abstract][Full Text] [Related]
37. Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeks.
Robaeys G; De Bie J; Wichers MC; Bruckers L; Nevens F; Michielsen P; Van Ranst M; Buntinx F
World J Gastroenterol; 2007 Nov; 13(43):5736-40. PubMed ID: 17963300
[TBL] [Abstract][Full Text] [Related]
38. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.
Kraus MR; Schäfer A; Faller H; Csef H; Scheurlen M
Aliment Pharmacol Ther; 2002 Jun; 16(6):1091-9. PubMed ID: 12030950
[TBL] [Abstract][Full Text] [Related]
39. Asymmetric dimethylarginine responses during interferon-α-induced depression in patients with chronic hepatitis C infection.
Baranyi A; Meinitzer A; Putz-Bankuti C; Stauber R; Kapfhammer HP; Rothenhäusler HB
Psychosom Med; 2014 Apr; 76(3):197-207. PubMed ID: 24608038
[TBL] [Abstract][Full Text] [Related]
40. Role of the Allelic Variation in the 5-Hydroxytryptamine Receptor 1A (HTR1A) and the Tryptophan Hydroxylase 2 (TPH2) Genes in the Development of PTSD.
Goçi Uka A; Agani F; Blyta A; Hoxha B; Haxhibeqiri S; Haxhibeqiri V; Sabic Dzananovic E; Kucukalic S; Bravo Mehmedbasic A; Kucukalic A; Dzubur-Kulenovic A; Feric Bojic E; Marjanovic D; Kravic N; Avdibegovic E; Muminovic Umihanic M; Jaksic N; Cima Franc A; Rudan D; Jakovljevic M; Babic R; Pavlovic M; Babic D; Aukst Margetic B; Bozina N; Sinanovic O; Ziegler C; Warrings B; Domschke K; Deckert J; Wolf C
Psychiatr Danub; 2019 Jun; 31(2):256-262. PubMed ID: 31291234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
